Optimising treatment duration with immunomodulators to reduce overtreatment

Verifisert
National Institute for Health and Care Research
Type
Tilskudd
Frist
Utløpt 2. desember 2025
Program
Efficacy and Mechanism Evaluation

Om ordningen

- Funding programme: Efficacy and Mechanism Evaluation - Opening date: 2025-07-31 - Closing date: 2025-12-02

The MRC-NIHR Efficacy and Mechanism Evaluation (EME) Programme is inviting applications for research into optimising treatment duration with immunomodulators to reduce overtreatment.

Full eligibility, award value and application detail are published on the opportunity's own page: https://www.nihr.ac.uk/funding/optimising-treatment-duration-immunomodulators-reduce-overtreatment/2025370

Ofte stilte spørsmål

Hvem står bak Optimising treatment duration with immunomodulators to reduce overtreatment?
Optimising treatment duration with immunomodulators to reduce overtreatment er en tilskudd fra National Institute for Health and Care Research.
Hvordan søker man på Optimising treatment duration with immunomodulators to reduce overtreatment?
Du søker hos National Institute for Health and Care Research via lenken på denne siden. Virkely hjelper deg å skrive selve søknaden — fra organisasjonsnummer til ferdig tekst.

Skal du søke Optimising treatment duration with immunomodulators to reduce overtreatment?

Virkely hjelper deg å skrive søknaden — fra organisasjonsnummer til ferdig tekst. Ingen innlogging.

Start søknaden

Flere ordninger fra National Institute for Health and Care Research